ArticleCureus2026
Marrow to Bowel or Bowel to Marrow: Intestinal Myeloid Sarcoma Presenting With Acute Obstruction.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myeloid sarcoma (MS) is an extramedullary tumor composed of immature myeloid precursor cells and represents a tissue manifestation of acute myeloid leukemia (AML). It may occur concurrently with AML, precede marrow disease, or present at relapse. Gastrointestinal (GI) involvement is uncommon and frequently poses a diagnostic challenge due to morphological overlap with lymphoid and other GI malignancies. We report the case of a 38-year-old man presenting with acute intestinal obstruction secondary to a duodenal-jejunal mass. Histopathological examination demonstrated diffuse submucosal infiltration by monomorphic abnormal cells, initially raising a differential diagnosis of lymphoma or poorly differentiated malignancy, intestinal tuberculosis, or gastrointestinal stromal tumor. Immunohistochemistry revealed strong myeloperoxidase positivity, with negativity for epithelial, lymphoid, and neuroendocrine markers, supporting myeloid lineage. Peripheral blood examination showed leukocytosis with circulating blasts and monocytic precursors. Multiparametric flow cytometry was suggestive of AML with monocytic differentiation, establishing the diagnosis of intestinal MS with concurrent AML. The present case highlights the rarity of MS presenting as an acute abdomen and surgical emergency with diagnostic challenges to the surgeon. Accurate diagnosis relies on keeping a high index of clinical suspicion, along with a multidisciplinary approach. Early identification is critical, as MS requires prompt AML-directed systemic therapy rather than localized surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.